Core Viewpoint - The article discusses the IPO application of Beijing Plant Doctor Cosmetics Co., Ltd., highlighting its challenges in transitioning from a predominantly offline retail model to a more balanced online presence in the beauty industry [1][3]. IPO Details - Beijing Plant Doctor's IPO has been accepted by the Shenzhen Stock Exchange, with a projected fundraising amount of approximately 9.98 billion yuan [2]. - The company signed an IPO counseling agreement in 2023 and has only recently received acceptance from the exchange [2]. Business Model and Market Position - Plant Doctor operates over 4,000 offline stores and is considered a strong competitor for the title of "first beauty single brand stock" [3]. - The company has been criticized for its heavy reliance on offline channels, which has led to missed opportunities in the online market [3]. - In 2024, online direct sales accounted for only 9.3% of total revenue, indicating a significant lag behind competitors [6]. Revenue and Store Performance - The total number of stores decreased from 4,664 to 4,328 in 2024, with a net reduction of 336 stores [7]. - Despite the reduction in store count, revenue growth was minimal, increasing from 21.55 billion yuan to 21.557 billion yuan [7]. - The company has been optimizing its store network by closing underperforming locations, but this has not translated into revenue growth [7]. Online Sales and Competitor Comparison - Plant Doctor's online sales growth is significantly behind competitors like Proya, whose online direct sales accounted for over 75% of its revenue in 2024 [6]. - The company's online retail platform, "Xiaozhi Mall," has seen a decline in revenue from 839 million yuan in 2022 to 623 million yuan in 2024 [6]. Gross Margin and Distribution Model - The company primarily uses a distribution model, with over 63% of its revenue coming from this channel over the past three years, which has negatively impacted its gross margin [9]. - In 2024, Plant Doctor's overall gross margin was 58.9%, compared to Proya's 71.41% [9]. Inventory and Financial Metrics - As of May 31, 2025, 32 subsidiaries and stores have not obtained the necessary health permits for providing in-store services [10]. - The company's inventory turnover efficiency has declined from 4.96 times to 4.27 times from 2022 to 2024, with inventory balance at 223 million yuan [10]. - Key financial metrics include a current ratio of 2.21 and a debt-to-asset ratio of 44.97% [11]. Private Traffic Strategy - Plant Doctor emphasizes the importance of private traffic in its growth strategy, aiming to integrate offline and online channels through its private platform [13]. - The company claims that its private traffic team has developed standardized procedures that have generated significant revenue, although recent data shows a decline in revenue from its online platform [14].

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][29]. Core Insights - The report highlights significant market performance for the week of June 23-27, 2025, with retail, social services, and beauty care sectors increasing by 4.56%, 4.61%, and 1.04% respectively, outperforming the Shanghai Composite Index which rose by 1.91% [14][17]. - Key events include the strategic investment of 3.4 billion yuan by Jianbo Biological into Yangshengtang, and the successful IPO of Yingtong Holdings on the Hong Kong Stock Exchange [3][28]. Summary by Sections Market Performance - The retail, social services, and beauty care sectors ranked 9th, 8th, and 24th among 31 primary industries, with notable increases in sub-sectors such as education, professional chains, and trade, which rose by 7.47%, 7.42%, and 5.2% respectively [14][17]. Key Industry Data and News - In the beauty care sector, significant developments include the entry of Kefu Mei into Malaysia's Watsons, becoming the first Chinese efficacy skincare brand in the region, and the announcement by the National Medical Products Administration regarding the management of cosmetic raw materials [23][24]. - Jianbo Biological's restructuring of its collagen product to a medical device category and the successful listing of Yingtong Holdings are also noteworthy [3][24]. Investment Recommendations - The report recommends focusing on companies such as Shangmei Co., Ltd., Juzhi Biological, Marubi Biological, Runben Co., Ltd., Proya, Chaohongji, Blukoo, and Furuida as potential investment targets within the highlighted sectors [5][29].

展望后市，星石投资表示，短期看，海外风险边际下行，行业亮点不断，股市活跃资金偏多的背景下， 市场情绪有望延续修复。即将进入7月，中报预告叠加市场预期7月底或有新的政策定调，预计后续业绩 端和政策端对市场的影响或有所加大。 □本报记者 王宇露 中期视角下，星石投资认为，虽然海外关税因素尚未完全明确，但国内政策发力应对是较为确定的。随 着宏观政策持续为经济复苏提供助力，国内经济基本面预期逐步改善，中期股市情绪中枢也不弱,叠加 当前股市估值并不算高，A股权益类资产依旧具有较强的中长期投资性价比。 上周市场上涨，中证新华社民族品牌工程指数（简称"品牌工程指数"）上涨2.17%，报1627.35点。从成 分股的表现看，恒生电子、东方财富、新宝股份等成分股上周表现强势；年初以来，信立泰、安集科 技、丸美生物等成分股涨幅居前。展望后市，机构认为，随着宏观政策持续为经济复苏提供助力，国内 经济基本面预期逐步改善，叠加当前股市估值并不算高，A股权益类资产依旧具有较强的中长期投资性 价比。 相聚资本研究总监、基金经理余晓畅认为，下半年经济本身不是决定股市走向的胜负手，而是可能出现 的变局点，也对应着股市的变盘。宏观经济之外，新兴 ...

中信证券股份有限公司 关于广东丸美生物技术股份有限公司 2024年年度报告的 信息披露监管问询函回复的核查意见 上海证券交易所: 贵所《关于广东丸美生物技术股份有限公司 2024 年年度报告的信息披露监管 问询函》(上证公函【2025】0714 号)已收悉,中信证券股份有限公司(以下简称 "中信证券"或"保荐机构")作为广东丸美生物技术股份有限公司(以下简称"丸 美生物"或"公司")的持续督导保荐机构,会同公司及相关中介机构,对问询函所 提及的相关事项进行了认真核查落实,现将问询函所涉及问题回复如下,请予审核。 三、关于在建工程 年报披露,公司期末在建工程 6.03 亿元,其中"营销升级及运营总部建设" 6.01亿元,工程进度 90.76%,"化妆品智能制造工厂建设项目"0.72亿元,工程进 度 95. 94%。报告期内公司将上述两项募投项目预定可使用状态日期分别延期至 2026 年 9 月、2025年 12 月,项目进展较为缓慢。现金流量表显示,公司近三年购建固 定资产、无形资产和其他长期资产支付的现金分别为 1. 11 亿元、22.54 亿元、3. 16 亿元。 请公司:(1)补充披露上述项目的具体实施进 ...

关于广东丸美生物技术股份有限公司 2024 年年度报告的信息披露问询函的回复 华兴专字[2025]24012360165 号 华兴会计师事务所(特殊普通合伙) 计师事务所(特殊普 CERTIFIED PUBLIC ACCOUN 东路152号中山大厦B座6-9楼 Add : 6-9/F Block B,152 Hudong Road,Fuzhou,Fujian,China 电话(Tel):0591-87852574 Http://www.fjhxcpa.com 邮政编码(Postcode):350003 关于广东丸美生物技术股份有限公司 2024 年年度报告的信息披露问询函的回复 华兴专字[2025]24012360165 号 上海证券交易所: 由广东丸美生物技术股份有限公司(以下简称"丸美生物"或"公司")转来的 《关于广东丸美生物技术股份有限公司 2024年年度报告的信息披露监管问询函》 (以下简称"间询函")已收悉,华兴会计师事务所(特殊普通合伙)(以下简称"会 计师"或"我们")作为丸美生物 2024 年年报审计机构,就有关涉及会计师说明或 发表意见的问题,进行了认真分析与核查,现根据问询函所涉问题进行 ...

一、关于货币资金。 证券代码:603983 证券简称:丸美牛物 公告编号:2025-017 广东丸美生物技术股份有限公司 关于 2024 年年度报告的信息披露监管问询函的回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 广东丸美生物技术股份有限公司(以下简称"公司"或"丸美生物")于近期 收到上海证券交易所 《关于广东丸美生物技术股份有限公司 2024年年度报告的信 息披露监管问询函》(上证公函【2025】0714号),公司在收到后高度重视,现就 信息披露监管问询函相关问题回复如下: 年报披露,报告期末公司货币资金 20.32亿元,同比增加 88.73%,占总资产比 重 40.14%,其中受限货币资金 4.36 亿元,公司未披露受限资金具体情况。报告期 末公司短期借款 7.90 亿元,同比增加 689.53%。 请公司:(1)补充披露主要货币资金存放情况,包括存放机构、金额、账户 性质、利率、受限情况等,并逐项列示受限资金的具体情况,包括受限金额、受限 期限、受限原因等;(2)结合流动性需求、借款规模变动情况、存贷收益 ...

Core Viewpoint - The beauty industry is experiencing an "enzyme ingredient revolution" with domestic brands innovating and focusing on enzyme-based skincare products, indicating a shift in consumer preferences towards gentler and more effective solutions [4][14][25]. Group 1: Enzyme Ingredients in Skincare - Enzymes have been a "silent hero" in cosmetic formulations, with 31 types of enzyme ingredients already used in effective registered cosmetics, with superoxide dismutase (SOD) leading with 15,285 registrations [6][12]. - Major brands like Proya and Marubi are incorporating SOD and other enzymes like coenzyme Q10 and papain into their products, highlighting the growing trend of enzyme usage in skincare [11][21]. - The focus on composite enzymes, such as Proya's "3X Smart Enzyme," aims to provide a dual benefit of effective exfoliation and gentle repair, catering to consumer demands for non-irritating skincare solutions [15][23]. Group 2: Market Trends and Consumer Insights - The demand for enzyme-based products is driven by consumers seeking effective yet gentle solutions for skin concerns, particularly for oily skin types and sensitive skin [23][25]. - The global enzyme preparation market is projected to grow to $15 billion by 2035, with a compound annual growth rate (CAGR) of approximately 3.61% from 2025 to 2035, indicating a stable growth trajectory for enzyme-based products [39]. - The enzyme market is highly concentrated, with five companies, including Novozymes and DuPont, holding about 75% of the global market share, reflecting the competitive landscape [40]. Group 3: Technological Advancements and Challenges - Advances in biotechnology are enhancing the stability and efficacy of enzyme ingredients, with companies employing gene editing and nanotechnology to improve product performance [41][43]. - Despite the potential, challenges remain in enzyme application due to their large molecular size and sensitivity to environmental factors, which complicates their formulation in cosmetics [36][37]. - The industry is facing a dual bottleneck: insufficient technical conversion in production and a lack of consumer awareness regarding enzyme benefits, which hinders market penetration [44][45]. Group 4: Future Outlook - The trend of "using enzymes instead of acids" is emerging, suggesting a potential coexistence of enzyme and acid products in the market, each serving different consumer needs [46][47]. - The establishment of standards for enzyme-based skincare products is underway, which may enhance product credibility and consumer trust in enzyme efficacy [47].

Investment Rating - The report maintains an "Outperform" rating for the industry [1] Core Insights - The rise of new consumption is fundamentally driven by a significant change in consumer concepts shaped by the economic and social context of different generations, particularly from the 70s to the 00s [4][5] - The current consumer market is characterized by a shift from "survival-type" products to "quality + emotional-type" products, with a focus on emotional value and quality-price ratio [4][10] - Investment logic in new consumption should focus on sustainable growth capabilities rather than short-term speculative opportunities, emphasizing product innovation and strong brand recognition [4] Summary by Sections 1. Economic and Demographic Background of Consumption Changes - The per capita GDP in China has grown from over 10,000 RMB in 1995 to 84,000 RMB in 2023, establishing a buyer's market [4][15] - Consumer spending is increasingly constrained by rigid expenditures on housing, healthcare, and education, alongside wealth effects [4][19] - The educational attainment of the 95/00 generation has significantly increased, with a CAGR of 10.5% in the number of undergraduate graduates from 1998 to 2023 [4][23] - Urbanization rates have remained high, influencing consumption patterns and driving the reconstruction of consumption scenarios [4][24] 2. Product Evolution - The transition in consumer products reflects a shift towards quality and emotional engagement, with head brands focusing on domestic alternatives and functional trends [4][10] - The market has seen a rise in low-cost, emotionally valuable products, such as beauty care, jewelry, and IP toys, which are now key segments [4][10] 3. Marketing Evolution - Marketing strategies have evolved from traditional brand advertising to performance-driven advertising, with a focus on maximizing advertising efficiency [4][10] - The rise of digital platforms has transformed marketing channels, emphasizing the importance of consumer engagement and conversion rates [4][10] 4. Channel Evolution - The shift towards online channels has significantly increased penetration rates across various categories, with a focus on consumer value rather than supplier value [4][10] - The integration of public and private domains has become crucial for navigating the challenges posed by traditional retail models [4][10]

Core Viewpoint - The acquisition of the functional skincare brand Baizhicui by the makeup brand Judo's parent company, Juyi Group, marks its official entry into the skincare sector, reflecting a broader trend of multi-brand and cross-category development in the beauty industry [1][2]. Category Expansion: Skincare/Makeup/Medical Devices - Skincare brands are primarily venturing into makeup and fragrance, while makeup brands are increasingly extending their reach into skincare [3][4]. - The mainstream choice for skincare brands entering the makeup market is to launch base makeup products, followed by fragrances [5]. Skincare Brands Entering Makeup Market - Notable brands like Proya, Han Shu, and Baique Ling have launched cushion products, while others like Natural Hall and Oushiman have introduced foundation products [5][6]. Skincare Brands Focusing on Medical Devices - Skincare brands are showing a strong interest in the medical device category, primarily launching products featuring recombinant collagen [6][7]. Makeup Brands Entering Skincare Market - Makeup brands are primarily focusing on masks as their first choice for skincare products, followed by serums and creams [8][9]. - The low technical requirements and acceptance of masks make them an attractive entry point for makeup brands [10]. Product Pricing Strategies - Skincare brands typically price their makeup products below 200 yuan, with many under 100 yuan, while makeup brands entering skincare tend to target mid to high-end price ranges [13][14]. - Medical device products from skincare brands have a wider pricing range, with some products priced as high as 300 yuan [13]. Market Performance - Sales figures for newly launched products vary significantly, with some brands achieving over 10,000 units sold, while others struggle to reach even 100 [15][16]. - For instance, the luxury caviar mask from Mao Ge Ping has sold over 100,000 units, contributing significantly to the brand's revenue [17]. Challenges in Cross-Category Development - The drive for cross-category development is largely due to rising traffic and customer acquisition costs, as well as the saturation of single-category growth [18]. - Successful cross-category ventures depend on the ability to transfer existing consumer perceptions to new product categories [19].

Group 1: Meitu Company (美图公司) - Meitu is a leading domestic imaging software company that started with Meitu Xiuxiu in 2008, accumulating deep technical capabilities and aesthetic data over the years [3][13] - The company has undergone significant changes in its fundamentals since 2023, including a management change and a focus on core business areas, with the founder taking over as chairman [13] - The introduction of GenAI has enhanced product capabilities, expanding both consumer and business applications, with a strategic partnership with Alibaba to promote Meitu's AI tools on e-commerce platforms [13] - The company is expected to achieve adjusted net profits of 8.51, 11.63, and 15.09 billion CNY from 2025 to 2027, with a target market value of 46.6 billion HKD, indicating a potential upside of 33% [3][13] Group 2: Lin Tai New Materials (林泰新材) - Lin Tai New Materials is the only domestic supplier of wet paper-based friction plates for passenger vehicles, breaking the monopoly in the market [3][12] - The company has seen significant growth, with revenue and net profit increasing by 107% and 288% year-on-year in Q1 2025, driven by projects with major clients like BYD and Geely [12][15] - The market for automatic transmission friction plates is expected to grow significantly, with a projected market size of 5.112 billion CNY by 2035 [12][15] - The company is expected to achieve net profits of 1.53, 2.19, and 2.83 billion CNY from 2025 to 2027, with a target market value of 6.832 billion CNY, indicating a potential upside of 30.4% [12][15] Group 3: Guangbo Co., Ltd. (广博股份) - Guangbo is accelerating its transformation into IP cultural and creative products, leveraging its traditional stationery manufacturing advantages [17][18] - The company is expected to generate 1.87 billion CNY in revenue from IP cultural and creative products in 2024, accounting for 7% of total revenue [17][18] - The IP derivative market is projected to reach 174.2 billion CNY in GMV in 2024, with a growth rate of 30.2% [17][18] - The company has developed several sub-brands and has successfully obtained IP licenses for popular franchises, enhancing its product offerings [17][18] Group 4: Debt Market Analysis - The report defines a "debt bull market" as a period where the 10Y government bond yield is in a downward trend, lasting at least one month with a decline of at least 20 basis points [5][14] - Since 2022, there have been four instances of "debt bull markets," typically occurring during periods of economic downturn and credit contraction [5][14] - The report emphasizes that the fundamental economic outlook and a loose monetary environment are crucial for the initiation of a debt bull market [5][14]